The study, authored by Clare Bailey, Divisional Director of Healthcare Professionals, Cancer and Clinical Support at Barking, Havering and Redbridge University Hospitals NHS Trust, shows how Radiometer’s POCT ABL90 FLEX PLUS blood gas analysers and AQT90 FLEX immunoassay analysers have enabled the ED team to manage increasing patient numbers and deliver high-quality care.
Commenting on Radiometer’s POCT analysers, Clare Bailey said: “The benefits of the ABL90 FLEX PLUS blood gas analyser are clear. It measures urea and blood urea nitrogen (BUN) on very small sample volumes, which helps in the stratification of patients with suspected gastrointestinal bleeding, respiratory infections or dehydration.
Additionally, it is one of the few POCT instruments on the market that can also measure creatinine and it’s important for our department to have this capability because we can triage our patients more quickly. On top of that, we also have the AQT90 FLEX analyser, which was a great benefit for the ED staff, because it measures, for example, troponins, D-dimer and CRP – having all three was a real game-changer for us.”
For further information, please contact:
Radiometer Ltd, Manor Court, Manor Royal, Crawley RH10 9FY, UK
T: +44 (0) 1293 517599; E: email@example.com
About Queen’s Hospital
Queen’s Hospital in Romford is part of the Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT) in London, UK. Clare Bailey is the Divisional Director of Healthcare Professionals, Cancer and Clinical support at the BHRUT.
Radiometer develops, manufactures and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing and the related IT management systems. Radiometer’s products and services simplify and automate all phases of acute care testing, so hospitals can get fast results, optimise their workload, reduce the risk of errors, and improve cost effectiveness.